Alice Babst, MD
Obstetrics & Gynecology · Lake Charles, LANPI 1134162753
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (55.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 77.8% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $6,638, more than ten times the $339 reported in 2019. Among obstetrics & gynecology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 112 payments — averaging $72.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- AbbVie$295
- Hologic Sales And Service, LLC$246
- Mayne Pharma Commercial LLC$219
- Biohaven Pharmaceuticals, Inc.$125
- Endo Pharmaceuticals Inc.$109
- plus $799 from 19 others
Across 1 payment — averaging $3000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$3K
What the payments were for
- Travel & lodging$1,59620%
- Food & beverage$1,97124%
- Education$4,51556%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 15 | $6,289 |
| AbbVie(2 entities) | 17 | $295 |
| Hologic Sales And Service, LLC | 14 | $246 |
| Mayne Pharma Commercial LLC | 10 | $219 |
| Biohaven Pharmaceuticals, Inc. | 1 | $125 |
| Endo Pharmaceuticals Inc. | 6 | $109 |
| Pfizer | 6 | $104 |
| Evofem Biosciences, Inc. | 6 | $83 |
| Novo Nordisk | 5 | $74 |
| Sage Therapeutics, LLC | 4 | $73 |
| Sumitomo Pharma America, Inc. | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $63 |
| Millicent US Inc | 3 | $57 |
| Avion Pharmaceuticals | 3 | $41 |
| Shield Therapeutics Inc | 2 | $36 |
| Exeltis, USA Inc. | 2 | $29 |
| Merck | 2 | $27 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Bayer | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $16 |
| Exact Sciences | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Scynexis, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$4,500
- Da Vinci Surgical System$1,571
- NURTEC ODT$125
- Orilissa$102
How this compares
$8,082 in reported general payments places this provider in the 90th percentile of 608 obstetrics & gynecology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 29 | $1,172 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Lake Charles
- Joseph SemienLake Charles$11K
- James BrownLake Charles$6K
- Veronica GillispieNew Orleans$117K
- Rachel Bezdekla Place$105K
- Earl PeeperNew Orleans$95K
- Thomas PayneBaton Rouge$84K
- Catherine VanderloosShreveport$55K
- George MorrisNew Orleans$34K
- Russell PhelpsLafayette$31K
- Rachelle MeauxLafayette$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.